KLKb11 Inhibitors
KLKb11 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the KLKb11 enzyme, also known as kallikrein-related peptidase 11. KLKb11 is a member of the kallikrein family, a group of serine proteases that play a role in various physiological processes, including proteolysis and the regulation of other proteases. The enzyme operates by cleaving peptide bonds in specific substrates, which in turn affects the activity of downstream molecules. Inhibitors of KLKb11 are typically small molecules that interact with the active site of the enzyme or allosteric sites, thereby preventing it from binding to its natural substrates. This inhibition can occur through covalent or non-covalent interactions, depending on the structure of the inhibitor and its binding affinity to KLKb11. Some KLKb11 inhibitors are designed to be highly selective, ensuring that they do not affect other enzymes in the kallikrein family.
The chemical structure of KLKb11 inhibitors can vary significantly, but many include functional groups that interact with the serine residue in the enzyme's catalytic triad, which is essential for its protease activity. Researchers often optimize these inhibitors for properties like solubility, stability, and bioavailability, which ensure that they can effectively inhibit KLKb11 under physiological conditions. The study of KLKb11 inhibitors is important in understanding enzyme regulation and protease networks, as well as their broader biochemical role in controlling protein cascades. By studying these inhibitors, researchers gain insight into how enzyme kinetics can be modulated through specific chemical interactions, which further deepens our understanding of protease activity in various biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylase, potentially leading to the expanded chromatin structure that could result in the downregulation of KLKb11 expression due to decreased transcription factor binding. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By inhibiting DNA methyltransferase, 5-Aza-2′-Deoxycytidine could decrease DNA methylation levels, which may lead to the downregulation of KLKb11 by making the gene more accessible for transcription repression machinery. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid specifically inhibits histone deacetylases, which could lead to the hypoacetylation of histone proteins and the subsequent reduction in KLKb11 expression through tighter chromatin structure. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may inhibit histone deacetylase activity, resulting in alterations to chromatin structure that could decrease KLKb11 gene expression by limiting transcriptional activator access. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been reported to downregulate expression of certain genes by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), which may result in decreased KLKb11 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to downregulate the expression of specific genes by inhibiting the phosphorylation of signal transducer and activator of transcription 3 (STAT3), potentially including KLKb11. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate may reduce KLKb11 expression by inhibiting the activation of epidermal growth factor receptor (EGFR), which is known to play a role in gene expression related to cell proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, by inhibiting phosphoinositide 3-kinases (PI3K), could lead to the reduction of AKT phosphorylation and potentially inhibit downstream signals that promote KLKb11 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 specifically inhibits mitogen-activated protein kinase kinase (MEK), which could result in the downregulation of KLKb11 by inhibiting the MAPK/ERK signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), which may lead to the decreased expression of KLKb11 by altering the transcriptional activity of AP-1, a transcription factor involved in cell proliferation and differentiation. | ||||||